BIOMARIN PHARMACEUTICAL (BMRN) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
BIOMARIN PHARMACEUTICAL insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $4.3M of BMRN stock on the open market.
Get emailed when insiders cluster-buy stocks like BMRN
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BMRN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.2M | 1 |
| Q2 2026 | — | 0 | $177K | 1 |
| Q1 2026 | — | 0 | $3.0M | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 BIOMARIN PHARMACEUTICAL INC insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $4.3M. 0 of 5 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 3SEC | George Eric DavisGeneral Counsel | Sell | 17,55761,003 held (−22%) | $66.28 | $1.2M | -17.3% | — |
| May 11SEC | Gregory R FribergEvp, Chief R&D Officer | Sell | 3,28151,818 held (−6%) | $53.85 | $177K | +1.8% | — |
| Mar 12SEC | Charles Greg GuyerEvp, Chief Technical Officer | Sell | 16,48679,953 held (−17%) | $60.46 | $997K | -9.4% | — |
| Feb 26SEC | George Eric DavisGeneral Counsel | Sell | 26,06172,453 held (−26%) | $61.36 | $1.6M | -10.7% | — |
| Feb 26SEC | Gregory R FribergEvp, Chief R&D Officer | Sell | 6,32637,578 held (−14%) | $60.38 | $382K | -9.2% | — |
Insiders at BIOMARIN PHARMACEUTICAL INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| George Eric DavisGeneral Counsel | — | $2.8M | Sep 3, 2026 | — |
| Charles Greg GuyerEvp, Chief Technical Officer | — | $997K | Mar 12, 2026 | — |
| Gregory R FribergEvp, Chief R&D Officer | — | $559K | May 11, 2026 | — |
BMRN stock: common questions
Are BIOMARIN PHARMACEUTICAL INC insiders buying BMRN stock?
In the past 12 months, 0 insiders reported open-market purchases of BMRN worth $0.
Are BIOMARIN PHARMACEUTICAL INC insiders selling BMRN stock?
3 insiders reported sales worth $4.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BMRN's 52-week range?
Over the past year BMRN has traded between $49.67 and $70.24. It last closed at $54.80 on Oct 9, 2026.